SCHEMBL6159034

SCHEMBL6159034

O=Cc1cccc(Oc2cccc(C3OCCO3)c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.42
MAOA P21397 7/20 0.40
MAOB P27338 7/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
NPC1 O15118 5/20 0.37
RAB9A P51151 4/20 0.37
POLB P06746 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
BLM P54132 1/20 0.36
MCL1 Q07820 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TLR4 O00206 1/20 0.35
TLR2 O60603 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9789661 0.90 ALDH1A1 (0.49) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL2281435 0.86 ALDH1A1 (0.42) SRCMAOAMAOBALDH1A1KDM4E
SCHEMBL10824462 0.81 TAAR1 (0.50) MAOBALDH1A1KDM4EKMT2AMEN1
SCHEMBL1134268 0.80 TEAD1 (0.36) ALDH1A1KDM4EKMT2AMEN1NPC1
SCHEMBL6196036 0.80 DRD2 (0.42) SRCMAOAMAOBALDH1A1KDM4E
SCHEMBL29995306 0.80 DRD2 (0.42) SRCMAOAMAOBALDH1A1KDM4E
SCHEMBL30631693 0.79 SRC (0.60) SRCMAOAMAOBALDH1A1KMT2A
SCHEMBL6849018 0.79 SRC (0.60) SRCMAOAMAOBALDH1A1KMT2A
SCHEMBL2534237 0.77 PARP10 (0.43) TAAR1
SCHEMBL20546811 0.77 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240324442-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-09-26 US disclosed
CN-118652279-A Organic electroluminescent material and device 环球展览公司 2024-09-17 CN disclosed
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240324442-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES KCNH2, KCNH3, KCNB2 SRC 3320/4885MAOA 1921/4885MAOB 822/4885
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP SRC 71/4885MAOA 4410/4885MAOB 3660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.